Skip to main content
DH
NASDAQ Technology

Definitive Healthcare Q2 Revenue Falls 9%, Goodwill Fully Impaired, Nasdaq Delisting Looms

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.699
Mkt Cap
$100.409M
52W Low
$0.62
52W High
$4.7
52W Position info
13% above low
Off High info
85% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

DH is trading near its 52-week low of $0.62 (13% above the low).

Summary

Definitive Healthcare reported Q2 2026 revenue of $55.2M, down 9% YoY, with a net loss of $7.5M. Goodwill is fully impaired, and the company faces a Nasdaq delisting deadline of December 15, 2026.


Key Events · Earnings and Guidance · DH

  • Revenue Decline Accelerates

    Q2 2026 revenue fell 9% YoY to $55.2M, missing the $55.48M consensus. Subscription revenue dropped to $52.8M from $58.2M a year ago.

  • Goodwill Fully Impaired

    A $197.2M non-cash goodwill impairment charge in Q1 2026 reduced goodwill to $0, reflecting sustained stock price declines and a market cap below book value.

  • Nasdaq Delisting Notice

    Received June 18, 2026, for failing to maintain a $1.00 minimum bid price. The company has until December 15, 2026, to regain compliance or face delisting.

  • Cost Cutting and Restructuring

    A restructuring plan reduced headcount by ~40 employees, incurring $1.1M in charges. Operating expenses declined 7% YoY in Q2, partially offsetting revenue weakness.


Analysis · DH · Technology

Definitive Healthcare's Q2 2026 results show a 9% revenue decline to $55.2M, missing consensus, and a net loss of $7.5M. The company fully impaired its remaining goodwill, leaving none on the balance sheet. A Nasdaq delisting notice adds urgency, with a December 15, 2026 deadline to regain compliance. While adjusted EBITDA of $14.6M and $170.9M in cash provide some runway, the combination of declining revenue, a sub-$1 stock price, and the delisting threat creates significant uncertainty for shareholders.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DH was trading at $0.70 on NASDAQ in the Technology sector, with a market capitalization of approximately $100.4M. The 52-week trading range was $0.62 to $4.70. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DH - Latest Insights

DH
Nov 05, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.13
Real-time Price: $1.22 info
Change: +$0.085 (+8%) info
Market Cap: $176.488M info
DH
Oct 01, 2026, 8:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.9361
Real-time Price: $1.22 info
Change: +$0.2789 (+30%) info
Market Cap: $176.488M info
DH
Sep 09, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $1.22 info
Change: +$0.185 (+18%) info
Market Cap: $176.488M info
DH
Sep 02, 2026, 9:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $1.22 info
Change: +$0.165 (+16%) info
Market Cap: $176.488M info
DH
Sep 02, 2026, 8:40 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $1.22 info
Change: +$0.205 (+20%) info
Market Cap: $176.488M info